+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Group A & C Meningococcal Polysaccharide Vaccine Market - Global Forecast 2026-2032- Product Image
Group A & C Meningococcal Polysaccharide Vaccine Market - Global Forecast 2026-2032- Product Image
Sale

Group A & C Meningococcal Polysaccharide Vaccine Market - Global Forecast 2026-2032

  • Report

  • 181 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6134270
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Group A & C Meningococcal Polysaccharide Vaccine Market is projected to reach USD 3.55 Billion in 2026. It is expected to continue growing at a CAGR of 7.36%, reaching USD 5.43 Billion by 2032.

Group A & C Meningococcal Polysaccharide Vaccines: Executive Overview

Group A & C meningococcal polysaccharide vaccines support prevention strategies against invasive meningococcal disease caused by serogroups A and C. Their role is shaped by outbreak response, travel requirements, military and institutional health programs, and national immunization policies. Strategic priorities include maintaining product quality, matching formulations to epidemiological needs, and strengthening delivery access in settings where meningococcal transmission risk is elevated.

Public-Health Priorities Are Reshaping Meningococcal Vaccine Use

The landscape is being transformed by broader emphasis on outbreak preparedness, targeted vaccination of people at elevated risk, and faster deployment during regional epidemics. Health authorities are also integrating meningococcal vaccination with surveillance, laboratory confirmation, case management, and cross-border coordination. Product selection increasingly reflects serogroup circulation, age-specific policy objectives, cold-chain capabilities, and the need to reach mobile, remote, or underserved populations.

Artificial Intelligence Strengthens Surveillance and Delivery Decisions

Artificial intelligence can improve meningococcal disease surveillance by identifying unusual case patterns, supporting analysis of laboratory and epidemiological data, and helping public-health teams prioritize investigations. It can also assist demand planning, stock monitoring, route optimization, and identification of communities with lower vaccination access. These benefits depend on representative data, transparent validation, privacy safeguards, and continued expert oversight; AI should support rather than replace clinical and public-health judgment.

Regional Insights: Different Delivery Conditions Require Localized Strategies

North America emphasizes risk-based immunization, institutional programs, travel-related protection, and robust safety monitoring. Latin America continues to require adaptable approaches for outbreak response, uneven access, and varied national schedules. Europe combines coordinated surveillance with country-specific immunization policies, while the Middle East places importance on mass gatherings, travel health, and rapid response capacity. Africa remains strongly influenced by epidemic preparedness, campaign logistics, and access in high-risk settings. Asia-Pacific presents diverse needs spanning dense urban populations, travel corridors, routine immunization development, and geographically remote communities.

Group Insights: Multilateral and Security Networks Shape Preparedness

ASEAN countries benefit from stronger regional information exchange and coordinated responses to population mobility, while BRICS members reflect varied disease burdens, manufacturing capabilities, and public-health infrastructures. The European Union supports cross-border surveillance and policy coordination, although implementation remains national. G7 members generally emphasize advanced safety monitoring, procurement resilience, and evidence-based policy. GCC states prioritize travel and mass-gathering preparedness alongside coordinated health services, and NATO members may require continuity plans for military personnel, deployed populations, and cross-border emergency response.

Country Insights: Policy and Epidemiology Drive National Priorities

Australia combines travel health, outbreak preparedness, and targeted protection for higher-risk populations. Brazil and Mexico must balance geographic diversity with rapid response and equitable access. Canada and the United States emphasize risk-based recommendations, institutional protection, and surveillance. China and India require strategies suited to large and diverse populations, while Japan and South Korea place strong emphasis on regulated delivery and monitoring. In Europe, France, Germany, Italy, Spain, and the United Kingdom align vaccination decisions with national surveillance, travel needs, and public-health guidance. Russia’s priorities include geographically extensive delivery systems, outbreak readiness, and continuity of supply.

Action Priorities for Industry and Public-Health Leaders

Leaders should align product planning with serogroup surveillance, national recommendations, and clearly defined high-risk populations. They should strengthen supply continuity through validated manufacturing, quality systems, and resilient cold-chain partnerships; support public-health agencies with training and outbreak-readiness tools; and design delivery models for remote and mobile communities. Evidence generation should address safety, program performance, and use in relevant age groups. Responsible digital investment should focus on interoperable surveillance, transparent analytics, cybersecurity, and measurable improvements in access and response time.

Methodology: Evidence-Based Executive Synthesis

This executive summary uses the specified market scope-Group A & C meningococcal polysaccharide vaccines-and organizes findings across the required regions, country groupings, and countries. The assessment synthesizes established public-health principles concerning meningococcal epidemiology, vaccination policy, outbreak response, travel health, supply systems, and digital surveillance. It intentionally excludes market estimates, market sizing, market shares, forecasts, and company-specific assessments. Regional and national observations are qualitative and should be validated against current local guidance, surveillance reports, regulatory decisions, and procurement conditions.

Conclusion: Preparedness, Access, and Evidence Define Sustainable Impact

Group A & C meningococcal polysaccharide vaccines remain relevant where serogroup-specific risk, outbreaks, travel, institutional exposure, or emergency preparedness justify targeted protection. Sustainable impact depends on connecting vaccination with surveillance, timely procurement, trained delivery networks, and equitable access. Across regions and country groups, leaders that combine locally appropriate policy with reliable evidence, resilient operations, and carefully governed digital tools will be better positioned to reduce preventable meningococcal disease.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Group A & C Meningococcal Polysaccharide Vaccine Market, by Administration Route
7.1. Introduction
7.2. Intramuscular
7.3. Subcutaneous
8. Group A & C Meningococcal Polysaccharide Vaccine Market, by Formulation
8.1. Introduction
8.2. Liquid
8.3. Lyophilized
9. Group A & C Meningococcal Polysaccharide Vaccine Market, by End User
9.1. Introduction
9.2. Clinics
9.3. Hospital
9.4. Public Health Centers
10. Group A & C Meningococcal Polysaccharide Vaccine Market, by Distribution Channel
10.1. Introduction
10.2. Hospital Pharmacy
10.3. Online Pharmacy
10.4. Retail Pharmacy
11. Group A & C Meningococcal Polysaccharide Vaccine Market, by Sales Type
11.1. Introduction
11.2. Private Sector
11.3. Public Sector
12. Group A & C Meningococcal Polysaccharide Vaccine Market, by Application
12.1. Introduction
12.2. Emergency Vaccination
12.2.1. Mass Vaccination Campaigns
12.2.2. Outbreak Response
12.3. Routine Immunization
12.4. Travel Vaccination
13. Group A & C Meningococcal Polysaccharide Vaccine Market, by Region
13.1. Introduction
13.2. Asia-Pacific
13.3. North America
13.4. Latin America
13.5. Europe
13.6. Middle East
13.7. Africa
14. Group A & C Meningococcal Polysaccharide Vaccine Market, by Group
14.1. Introduction
14.2. ASEAN
14.3. GCC
14.4. European Union
14.5. BRICS
14.6. G7
14.7. NATO
15. Group A & C Meningococcal Polysaccharide Vaccine Market, by Country
15.1. Introduction
15.2. United States
15.3. Canada
15.4. Mexico
15.5. Brazil
15.6. United Kingdom
15.7. Germany
15.8. France
15.9. Russia
15.10. Italy
15.11. Spain
15.12. China
15.13. India
15.14. Japan
15.15. Australia
15.16. South Korea
16. Competitive Landscape
16.1. Market Share Analysis, 2025
16.2. Market Concentration Analysis, 2025
16.2.1. Concentration Ratio (CR)
16.2.2. Herfindahl Hirschman Index (HHI)
16.3. Recent Developments & Impact Analysis, 2025
16.4. Product Portfolio Analysis, 2025
16.5. Benchmarking Analysis, 2025
17. Company Profiles
17.1. Bharat Biotech International Limited
17.2. Cadila Healthcare Limited
17.3. China National Pharmaceutical Group Co., Ltd.
17.4. GlaxoSmithKline plc
17.5. Hualan Biological Engineering Inc.
17.6. Panacea Biotec Limited
17.7. PT Bio Farma (Persero)
17.8. Sanofi S.A.
17.9. Serum Institute of India Private Limited
18. Key Experts
LIST OF FIGURES
FIGURE 1. Global Group A & C Meningococcal Polysaccharide Vaccine Market, Years Considered for the Study
FIGURE 2. Global Group A & C Meningococcal Polysaccharide Vaccine Market, Research Design
FIGURE 3. Global Group A & C Meningococcal Polysaccharide Vaccine Market, Research Framework
FIGURE 4. Global Group A & C Meningococcal Polysaccharide Vaccine Market, Data Triangulation
FIGURE 5. Global Group A & C Meningococcal Polysaccharide Vaccine Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Group A & C Meningococcal Polysaccharide Vaccine Market Size, by Administration Route, 2025 vs 2032 (%)
FIGURE 7. Global Group A & C Meningococcal Polysaccharide Vaccine Market Size, by Administration Route, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Group A & C Meningococcal Polysaccharide Vaccine Market Size, by Formulation, 2025 vs 2032 (%)
FIGURE 9. Global Group A & C Meningococcal Polysaccharide Vaccine Market Size, by Formulation, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Group A & C Meningococcal Polysaccharide Vaccine Market Size, by End User, 2025 vs 2032 (%)
FIGURE 11. Global Group A & C Meningococcal Polysaccharide Vaccine Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Group A & C Meningococcal Polysaccharide Vaccine Market Size, by Distribution Channel, 2025 vs 2032 (%)
FIGURE 13. Global Group A & C Meningococcal Polysaccharide Vaccine Market Size, by Distribution Channel, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Group A & C Meningococcal Polysaccharide Vaccine Market Size, by Sales Type, 2025 vs 2032 (%)
FIGURE 15. Global Group A & C Meningococcal Polysaccharide Vaccine Market Size, by Sales Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Group A & C Meningococcal Polysaccharide Vaccine Market Size, by Application, 2025 vs 2032 (%)
FIGURE 17. Global Group A & C Meningococcal Polysaccharide Vaccine Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Group A & C Meningococcal Polysaccharide Vaccine Market Size, by Region, 2025 vs 2032 (%)
FIGURE 19. Global Group A & C Meningococcal Polysaccharide Vaccine Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 20. Global Group A & C Meningococcal Polysaccharide Vaccine Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global Group A & C Meningococcal Polysaccharide Vaccine Market Size, by Country, 2025 vs 2032 (%)
FIGURE 22. Global Group A & C Meningococcal Polysaccharide Vaccine Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 23. Global Group A & C Meningococcal Polysaccharide Vaccine Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Group A & C Meningococcal Polysaccharide Vaccine Market Segmentation & Coverage
TABLE 2. Global Group A & C Meningococcal Polysaccharide Vaccine Market Size, 2017-2032 (USD Million)
TABLE 3. Global Group A & C Meningococcal Polysaccharide Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 4. Global Intramuscular Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Intramuscular Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Intramuscular Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Subcutaneous Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Subcutaneous Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Subcutaneous Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Group A & C Meningococcal Polysaccharide Vaccine Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 11. Global Liquid Market Size, by Region, 2017-2032 (USD Million)
TABLE 12. Global Liquid Market Size, by Group, 2017-2032 (USD Million)
TABLE 13. Global Liquid Market Size, by Country, 2017-2032 (USD Million)
TABLE 14. Global Lyophilized Market Size, by Region, 2017-2032 (USD Million)
TABLE 15. Global Lyophilized Market Size, by Group, 2017-2032 (USD Million)
TABLE 16. Global Lyophilized Market Size, by Country, 2017-2032 (USD Million)
TABLE 17. Global Group A & C Meningococcal Polysaccharide Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 18. Global Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 19. Global Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 20. Global Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 21. Global Hospital Market Size, by Region, 2017-2032 (USD Million)
TABLE 22. Global Hospital Market Size, by Group, 2017-2032 (USD Million)
TABLE 23. Global Hospital Market Size, by Country, 2017-2032 (USD Million)
TABLE 24. Global Public Health Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 25. Global Public Health Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 26. Global Public Health Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 27. Global Group A & C Meningococcal Polysaccharide Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 28. Global Hospital Pharmacy Market Size, by Region, 2017-2032 (USD Million)
TABLE 29. Global Hospital Pharmacy Market Size, by Group, 2017-2032 (USD Million)
TABLE 30. Global Hospital Pharmacy Market Size, by Country, 2017-2032 (USD Million)
TABLE 31. Global Online Pharmacy Market Size, by Region, 2017-2032 (USD Million)
TABLE 32. Global Online Pharmacy Market Size, by Group, 2017-2032 (USD Million)
TABLE 33. Global Online Pharmacy Market Size, by Country, 2017-2032 (USD Million)
TABLE 34. Global Retail Pharmacy Market Size, by Region, 2017-2032 (USD Million)
TABLE 35. Global Retail Pharmacy Market Size, by Group, 2017-2032 (USD Million)
TABLE 36. Global Retail Pharmacy Market Size, by Country, 2017-2032 (USD Million)
TABLE 37. Global Group A & C Meningococcal Polysaccharide Vaccine Market Size, by Sales Type, 2017-2032 (USD Million)
TABLE 38. Global Private Sector Market Size, by Region, 2017-2032 (USD Million)
TABLE 39. Global Private Sector Market Size, by Group, 2017-2032 (USD Million)
TABLE 40. Global Private Sector Market Size, by Country, 2017-2032 (USD Million)
TABLE 41. Global Public Sector Market Size, by Region, 2017-2032 (USD Million)
TABLE 42. Global Public Sector Market Size, by Group, 2017-2032 (USD Million)
TABLE 43. Global Public Sector Market Size, by Country, 2017-2032 (USD Million)
TABLE 44. Global Group A & C Meningococcal Polysaccharide Vaccine Market Size, by Application, 2017-2032 (USD Million)
TABLE 45. Global Emergency Vaccination Market Size, by Region, 2017-2032 (USD Million)
TABLE 46. Global Emergency Vaccination Market Size, by Group, 2017-2032 (USD Million)
TABLE 47. Global Emergency Vaccination Market Size, by Country, 2017-2032 (USD Million)
TABLE 48. Global Mass Vaccination Campaigns Market Size, by Region, 2017-2032 (USD Million)
TABLE 49. Global Mass Vaccination Campaigns Market Size, by Group, 2017-2032 (USD Million)
TABLE 50. Global Mass Vaccination Campaigns Market Size, by Country, 2017-2032 (USD Million)
TABLE 51. Global Outbreak Response Market Size, by Region, 2017-2032 (USD Million)
TABLE 52. Global Outbreak Response Market Size, by Group, 2017-2032 (USD Million)
TABLE 53. Global Outbreak Response Market Size, by Country, 2017-2032 (USD Million)
TABLE 54. Global Routine Immunization Market Size, by Region, 2017-2032 (USD Million)
TABLE 55. Global Routine Immunization Market Size, by Group, 2017-2032 (USD Million)
TABLE 56. Global Routine Immunization Market Size, by Country, 2017-2032 (USD Million)
TABLE 57. Global Travel Vaccination Market Size, by Region, 2017-2032 (USD Million)
TABLE 58. Global Travel Vaccination Market Size, by Group, 2017-2032 (USD Million)
TABLE 59. Global Travel Vaccination Market Size, by Country, 2017-2032 (USD Million)
TABLE 60. Global Group A & C Meningococcal Polysaccharide Vaccine Market Size, by Region, 2017-2032 (USD Million)
TABLE 61. Asia-Pacific Group A & C Meningococcal Polysaccharide Vaccine Market Size, by Region, 2017-2032 (USD Million)
TABLE 62. Asia-Pacific Group A & C Meningococcal Polysaccharide Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 63. Asia-Pacific Group A & C Meningococcal Polysaccharide Vaccine Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 64. Asia-Pacific Group A & C Meningococcal Polysaccharide Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 65. Asia-Pacific Group A & C Meningococcal Polysaccharide Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 66. Asia-Pacific Group A & C Meningococcal Polysaccharide Vaccine Market Size, by Sales Type, 2017-2032 (USD Million)
TABLE 67. Asia-Pacific Group A & C Meningococcal Polysaccharide Vaccine Market Size, by Application, 2017-2032 (USD Million)
TABLE 68. Asia-Pacific Group A & C Meningococcal Polysaccharide Vaccine Market Size, by Emergency Vaccination, 2017-2032 (USD Million)
TABLE 69. North America Group A & C Meningococcal Polysaccharide Vaccine Market Size, by Region, 2017-2032 (USD Million)
TABLE 70. North America Group A & C Meningococcal Polysaccharide Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 71. North America Group A & C Meningococcal Polysaccharide Vaccine Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 72. North America Group A & C Meningococcal Polysaccharide Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 73. North America Group A & C Meningococcal Polysaccharide Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 74. North America Group A & C Meningococcal Polysaccharide Vaccine Market Size, by Sales Type, 2017-2032 (USD Million)
TABLE 75. North America Group A & C Meningococcal Polysaccharide Vaccine Market Size, by Application, 2017-2032 (USD Million)
TABLE 76. North America Group A & C Meningococcal Polysaccharide Vaccine Market Size, by Emergency Vaccination, 2017-2032 (USD Million)
TABLE 77. Latin America Group A & C Meningococcal Polysaccharide Vaccine Market Size, by Region, 2017-2032 (USD Million)
TABLE 78. Latin America Group A & C Meningococcal Polysaccharide Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 79. Latin America Group A & C Meningococcal Polysaccharide Vaccine Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 80. Latin America Group A & C Meningococcal Polysaccharide Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 81. Latin America Group A & C Meningococcal Polysaccharide Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 82. Latin America Group A & C Meningococcal Polysaccharide Vaccine Market Size, by Sales Type, 2017-2032 (USD Million)
TABLE 83. Latin America Group A & C Meningococcal Polysaccharide Vaccine Market Size, by Application, 2017-2032 (USD Million)
TABLE 84. Latin America Group A & C Meningococcal Polysaccharide Vaccine Market Size, by Emergency Vaccination, 2017-2032 (USD Million)
TABLE 85. Europe Group A & C Meningococcal Polysaccharide Vaccine Market Size, by Region, 2017-2032 (USD Million)
TABLE 86. Europe Group A & C Meningococcal Polysaccharide Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 87. Europe Group A & C Meningococcal Polysaccharide Vaccine Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 88. Europe Group A & C Meningococcal Polysaccharide Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 89. Europe Group A & C Meningococcal Polysaccharide Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 90. Europe Group A & C Meningococcal Polysaccharide Vaccine Market Size, by Sales Type, 2017-2032 (USD Million)
TABLE 91. Europe Group A & C Meningococcal Polysaccharide Vaccine Market Size, by Application, 2017-2032 (USD Million)
TABLE 92. Europe Group A & C Meningococcal Polysaccharide Vaccine Market Size, by Emergency Vaccination, 2017-2032 (USD Million)
TABLE 93. Middle East Group A & C Meningococcal Polysaccharide Vaccine Market Size, by Region, 2017-2032 (USD Million)
TABLE 94. Middle East Group A & C Meningococcal Polysaccharide Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 95. Middle East Group A & C Meningococcal Polysaccharide Vaccine Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 96. Middle East Group A & C Meningococcal Polysaccharide Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 97. Middle East Group A & C Meningococcal Polysaccharide Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 98. Middle East Group A & C Meningococcal Polysaccharide Vaccine Market Size, by Sales Type, 2017-2032 (USD Million)
TABLE 99. Middle East Group A & C Meningococcal Polysaccharide Vaccine Market Size, by Application, 2017-2032 (USD Million)
TABLE 100. Middle East Group A & C Meningococcal Polysaccharide Vaccine Market Size, by Emergency Vaccination, 2017-2032 (USD Million)
TABLE 101. Africa Group A & C Meningococcal Polysaccharide Vaccine Market Size, by Region, 2017-2032 (USD Million)
TABLE 102. Africa Group A & C Meningococcal Polysaccharide Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 103. Africa Group A & C Meningococcal Polysaccharide Vaccine Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 104. Africa Group A & C Meningococcal Polysaccharide Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 105. Africa Group A & C Meningococcal Polysaccharide Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 106. Africa Group A & C Meningococcal Polysaccharide Vaccine Market Size, by Sales Type, 2017-2032 (USD Million)
TABLE 107. Africa Group A & C Meningococcal Polysaccharide Vaccine Market Size, by Application, 2017-2032 (USD Million)
TABLE 108. Africa Group A & C Meningococcal Polysaccharide Vaccine Market Size, by Emergency Vaccination, 2017-2032 (USD Million)
TABLE 109. Global Group A & C Meningococcal Polysaccharide Vaccine Market Size, by Group, 2017-2032 (USD Million)
TABLE 110. ASEAN Group A & C Meningococcal Polysaccharide Vaccine Market Size, by Group, 2017-2032 (USD Million)
TABLE 111. ASEAN Group A & C Meningococcal Polysaccharide Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 112. ASEAN Group A & C Meningococcal Polysaccharide Vaccine Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 113. ASEAN Group A & C Meningococcal Polysaccharide Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 114. ASEAN Group A & C Meningococcal Polysaccharide Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 115. ASEAN Group A & C Meningococcal Polysaccharide Vaccine Market Size, by Sales Type, 2017-2032 (USD Million)
TABLE 116. ASEAN Group A & C Meningococcal Polysaccharide Vaccine Market Size, by Application, 2017-2032 (USD Million)
TABLE 117. ASEAN Group A & C Meningococcal Polysaccharide Vaccine Market Size, by Emergency Vaccination, 2017-2032 (USD Million)
TABLE 118. GCC Group A & C Meningococcal Polysaccharide Vaccine Market Size, by Group, 2017-2032 (USD Million)
TABLE 119. GCC Group A & C Meningococcal Polysaccharide Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 120. GCC Group A & C Meningococcal Polysaccharide Vaccine Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 121. GCC Group A & C Meningococcal Polysaccharide Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 122. GCC Group A & C Meningococcal Polysaccharide Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 123. GCC Group A & C Meningococcal Polysaccharide Vaccine Market Size, by Sales Type, 2017-2032 (USD Million)
TABLE 124. GCC Group A & C Meningococcal Polysaccharide Vaccine Market Size, by Application, 2017-2032 (USD Million)
TABLE 125. GCC Group A & C Meningococcal Polysaccharide Vaccine Market Size, by Emergency Vaccination, 2017-2032 (USD Million)
TABLE 126. European Union Group A & C Meningococcal Polysaccharide Vaccine Market Size, by Group, 2017-2032 (USD Million)
TABLE 127. European Union Group A & C Meningococcal Polysaccharide Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 128. European Union Group A & C Meningococcal Polysaccharide Vaccine Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 129. European Union Group A & C Meningococcal Polysaccharide Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 130. European Union Group A & C Meningococcal Polysaccharide Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 131. European Union Group A & C Meningococcal Polysaccharide Vaccine Market Size, by Sales Type, 2017-2032 (USD Million)
TABLE 132. European Union Group A & C Meningococcal Polysaccharide Vaccine Market Size, by Application, 2017-2032 (USD Million)
TABLE 133. European Union Group A & C Meningococcal Polysaccharide Vaccine Market Size, by Emergency Vaccination, 2017-2032 (USD Million)
TABLE 134. BRICS Group A & C Meningococcal Polysaccharide Vaccine Market Size, by Group, 2017-2032 (USD Million)
TABLE 135. BRICS Group A & C Meningococcal Polysaccharide Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 136. BRICS Group A & C Meningococcal Polysaccharide Vaccine Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 137. BRICS Group A & C Meningococcal Polysaccharide Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 138. BRICS Group A & C Meningococcal Polysaccharide Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 139. BRICS Group A & C Meningococcal Polysaccharide Vaccine Market Size, by Sales Type, 2017-2032 (USD Million)
TABLE 140. BRICS Group A & C Meningococcal Polysaccharide Vaccine Market Size, by Application, 2017-2032 (USD Million)
TABLE 141. BRICS Group A & C Meningococcal Polysaccharide Vaccine Market Size, by Emergency Vaccination, 2017-2032 (USD Million)
TABLE 142. G7 Group A & C Meningococcal Polysaccharide Vaccine Market Size, by Group, 2017-2032 (USD Million)
TABLE 143. G7 Group A & C Meningococcal Polysaccharide Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 144. G7 Group A & C Meningococcal Polysaccharide Vaccine Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 145. G7 Group A & C Meningococcal Polysaccharide Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 146. G7 Group A & C Meningococcal Polysaccharide Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 147. G7 Group A & C Meningococcal Polysaccharide Vaccine Market Size, by Sales Type, 2017-2032 (USD Million)
TABLE 148. G7 Group A & C Meningococcal Polysaccharide Vaccine Market Size, by Application, 2017-2032 (USD Million)
TABLE 149. G7 Group A & C Meningococcal Polysaccharide Vaccine Market Size, by Emergency Vaccination, 2017-2032 (USD Million)
TABLE 150. NATO Group A & C Meningococcal Polysaccharide Vaccine Market Size, by Group, 2017-2032 (USD Million)
TABLE 151. NATO Group A & C Meningococcal Polysaccharide Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 152. NATO Group A & C Meningococcal Polysaccharide Vaccine Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 153. NATO Group A & C Meningococcal Polysaccharide Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 154. NATO Group A & C Meningococcal Polysaccharide Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 155. NATO Group A & C Meningococcal Polysaccharide Vaccine Market Size, by Sales Type, 2017-2032 (USD Million)
TABLE 156. NATO Group A & C Meningococcal Polysaccharide Vaccine Market Size, by Application, 2017-2032 (USD Million)
TABLE 157. NATO Group A & C Meningococcal Polysaccharide Vaccine Market Size, by Emergency Vaccination, 2017-2032 (USD Million)
TABLE 158. Global Group A & C Meningococcal Polysaccharide Vaccine Market Size, by Country, 2017-2032 (USD Million)
TABLE 159. United States Group A & C Meningococcal Polysaccharide Vaccine Market Size, 2017-2032 (USD Million)
TABLE 160. United States Group A & C Meningococcal Polysaccharide Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 161. United States Group A & C Meningococcal Polysaccharide Vaccine Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 162. United States Group A & C Meningococcal Polysaccharide Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 163. United States Group A & C Meningococcal Polysaccharide Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 164. United States Group A & C Meningococcal Polysaccharide Vaccine Market Size, by Sales Type, 2017-2032 (USD Million)
TABLE 165. United States Group A & C Meningococcal Polysaccharide Vaccine Market Size, by Application, 2017-2032 (USD Million)
TABLE 166. United States Group A & C Meningococcal Polysaccharide Vaccine Market Size, by Emergency Vaccination, 2017-2032 (USD Million)
TABLE 167. Canada Group A & C Meningococcal Polysaccharide Vaccine Market Size, 2017-2032 (USD Million)
TABLE 168. Canada Group A & C Meningococcal Polysaccharide Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 169. Canada Group A & C Meningococcal Polysaccharide Vaccine Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 170. Canada Group A & C Meningococcal Polysaccharide Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 171. Canada Group A & C Meningococcal Polysaccharide Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 172. Canada Group A & C Meningococcal Polysaccharide Vaccine Market Size, by Sales Type, 2017-2032 (USD Million)
TABLE 173. Canada Group A & C Meningococcal Polysaccharide Vaccine Market Size, by Application, 2017-2032 (USD Million)
TABLE 174. Canada Group A & C Meningococcal Polysaccharide Vaccine Market Size, by Emergency Vaccination, 2017-2032 (USD Million)
TABLE 175. Mexico Group A & C Meningococcal Polysaccharide Vaccine Market Size, 2017-2032 (USD Million)
TABLE 176. Mexico Group A & C Meningococcal Polysaccharide Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 177. Mexico Group A & C Meningococcal Polysaccharide Vaccine Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 178. Mexico Group A & C Meningococcal Polysaccharide Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 179. Mexico Group A & C Meningococcal Polysaccharide Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 180. Mexico Group A & C Meningococcal Polysaccharide Vaccine Market Size, by Sales Type, 2017-2032 (USD Million)
TABLE 181. Mexico Group A & C Meningococcal Polysaccharide Vaccine Market Size, by Application, 2017-2032 (USD Million)
TABLE 182. Mexico Group A & C Meningococcal Polysaccharide Vaccine Market Size, by Emergency Vaccination, 2017-2032 (USD Million)
TABLE 183. Brazil Group A & C Meningococcal Polysaccharide Vaccine Market Size, 2017-2032 (USD Million)
TABLE 184. Brazil Group A & C Meningococcal Polysaccharide Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 185. Brazil Group A & C Meningococcal Polysaccharide Vaccine Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 186. Brazil Group A & C Meningococcal Polysaccharide Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 187. Brazil Group A & C Meningococcal Polysaccharide Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 188. Brazil Group A & C Meningococcal Polysaccharide Vaccine Market Size, by Sales Type, 2017-2032 (USD Million)
TABLE 189. Brazil Group A & C Meningococcal Polysaccharide Vaccine Market Size, by Application, 2017-2032 (USD Million)
TABLE 190. Brazil Group A & C Meningococcal Polysaccharide Vaccine Market Size, by Emergency Vaccination, 2017-2032 (USD Million)
TABLE 191. United Kingdom Group A & C Meningococcal Polysaccharide Vaccine Market Size, 2017-2032 (USD Million)
TABLE 192. United Kingdom Group A & C Meningococcal Polysaccharide Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 193. United Kingdom Group A & C Meningococcal Polysaccharide Vaccine Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 194. United Kingdom Group A & C Meningococcal Polysaccharide Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 195. United Kingdom Group A & C Meningococcal Polysaccharide Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 196. United Kingdom Group A & C Meningococcal Polysaccharide Vaccine Market Size, by Sales Type, 2017-2032 (USD Million)
TABLE 197. United Kingdom Group A & C Meningococcal Polysaccharide Vaccine Market Size, by Application, 2017-2032 (USD Million)
TABLE 198. United Kingdom Group A & C Meningococcal Polysaccharide Vaccine Market Size, by Emergency Vaccination, 2017-2032 (USD Million)
TABLE 199. Germany Group A & C Meningococcal Polysaccharide Vaccine Market Size, 2017-2032 (USD Million)
TABLE 200. Germany Group A & C Meningococcal Polysaccharide Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 201. Germany Group A & C Meningococcal Polysaccharide Vaccine Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 202. Germany Group A & C Meningococcal Polysaccharide Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 203. Germany Group A & C Meningococcal Polysaccharide Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 204. Germany Group A & C Meningococcal Polysaccharide Vaccine Market Size, by Sales Type, 2017-2032 (USD Million)
TABLE 205. Germany Group A & C Meningococcal Polysaccharide Vaccine Market Size, by Application, 2017-2032 (USD Million)
TABLE 206. Germany Group A & C Meningococcal Polysaccharide Vaccine Market Size, by Emergency Vaccination, 2017-2032 (USD Million)
TABLE 207. France Group A & C Meningococcal Polysaccharide Vaccine Market Size, 2017-2032 (USD Million)
TABLE 208. France Group A & C Meningococcal Polysaccharide Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 209. France Group A & C Meningococcal Polysaccharide Vaccine Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 210. France Group A & C Meningococcal Polysaccharide Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 211. France Group A & C Meningococcal Polysaccharide Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 212. France Group A & C Meningococcal Polysaccharide Vaccine Market Size, by Sales Type, 2017-2032 (USD Million)
TABLE 213. France Group A & C Meningococcal Polysaccharide Vaccine Market Size, by Application, 2017-2032 (USD Million)
TABLE 214. France Group A & C Meningococcal Polysaccharide Vaccine Market Size, by Emergency Vaccination, 2017-2032 (USD Million)
TABLE 215. Russia Group A & C Meningococcal Polysaccharide Vaccine Market Size, 2017-2032 (USD Million)
TABLE 216. Russia Group A & C Meningococcal Polysaccharide Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 217. Russia Group A & C Meningococcal Polysaccharide Vaccine Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 218. Russia Group A & C Meningococcal Polysaccharide Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 219. Russia Group A & C Meningococcal Polysaccharide Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 220. Russia Group A & C Meningococcal Polysaccharide Vaccine Market Size, by Sales Type, 2017-2032 (USD Million)
TABLE 221. Russia Group A & C Meningococcal Polysaccharide Vaccine Market Size, by Application, 2017-2032 (USD Million)
TABLE 222. Russia Group A & C Meningococcal Polysaccharide Vaccine Market Size, by Emergency Vaccination, 2017-2032 (USD Million)
TABLE 223. Italy Group A & C Meningococcal Polysaccharide Vaccine Market Size, 2017-2032 (USD Million)
TABLE 224. Italy Group A & C Meningococcal Polysaccharide Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 225. Italy Group A & C Meningococcal Polysaccharide Vaccine Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 226. Italy Group A & C Meningococcal Polysaccharide Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 227. Italy Group A & C Meningococcal Polysaccharide Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 228. Italy Group A & C Meningococcal Polysaccharide Vaccine Market Size, by Sales Type, 2017-2032 (USD Million)
TABLE 229. Italy Group A & C Meningococcal Polysaccharide Vaccine Market Size, by Application, 2017-2032 (USD Million)
TABLE 230. Italy Group A & C Meningococcal Polysaccharide Vaccine Market Size, by Emergency Vaccination, 2017-2032 (USD Million)
TABLE 231. Spain Group A & C Meningococcal Polysaccharide Vaccine Market Size, 2017-2032 (USD Million)
TABLE 232. Spain Group A & C Meningococcal Polysaccharide Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 233. Spain Group A & C Meningococcal Polysaccharide Vaccine Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 234. Spain Group A & C Meningococcal Polysaccharide Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 235. Spain Group A & C Meningococcal Polysaccharide Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 236. Spain Group A & C Meningococcal Polysaccharide Vaccine Market Size, by Sales Type, 2017-2032 (USD Million)
TABLE 237. Spain Group A & C Meningococcal Polysaccharide Vaccine Market Size, by Application, 2017-2032 (USD Million)
TABLE 238. Spain Group A & C Meningococcal Polysaccharide Vaccine Market Size, by Emergency Vaccination, 2017-2032 (USD Million)
TABLE 239. China Group A & C Meningococcal Polysaccharide Vaccine Market Size, 2017-2032 (USD Million)
TABLE 240. China Group A & C Meningococcal Polysaccharide Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 241. China Group A & C Meningococcal Polysaccharide Vaccine Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 242. China Group A & C Meningococcal Polysaccharide Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 243. China Group A & C Meningococcal Polysaccharide Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 244. China Group A & C Meningococcal Polysaccharide Vaccine Market Size, by Sales Type, 2017-2032 (USD Million)
TABLE 245. China Group A & C Meningococcal Polysaccharide Vaccine Market Size, by Application, 2017-2032 (USD Million)
TABLE 246. China Group A & C Meningococcal Polysaccharide Vaccine Market Size, by Emergency Vaccination, 2017-2032 (USD Million)
TABLE 247. India Group A & C Meningococcal Polysaccharide Vaccine Market Size, 2017-2032 (USD Million)
TABLE 248. India Group A & C Meningococcal Polysaccharide Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 249. India Group A & C Meningococcal Polysaccharide Vaccine Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 250. India Group A & C Meningococcal Polysaccharide Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 251. India Group A & C Meningococcal Polysaccharide Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 252. India Group A & C Meningococcal Polysaccharide Vaccine Market Size, by Sales Type, 2017-2032 (USD Million)
TABLE 253. India Group A & C Meningococcal Polysaccharide Vaccine Market Size, by Application, 2017-2032 (USD Million)
TABLE 254. India Group A & C Meningococcal Polysaccharide Vaccine Market Size, by Emergency Vaccination, 2017-2032 (USD Million)
TABLE 255. Japan Group A & C Meningococcal Polysaccharide Vaccine Market Size, 2017-2032 (USD Million)
TABLE 256. Japan Group A & C Meningococcal Polysaccharide Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 257. Japan Group A & C Meningococcal Polysaccharide Vaccine Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 258. Japan Group A & C Meningococcal Polysaccharide Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 259. Japan Group A & C Meningococcal Polysaccharide Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 260. Japan Group A & C Meningococcal Polysaccharide Vaccine Market Size, by Sales Type, 2017-2032 (USD Million)
TABLE 261. Japan Group A & C Meningococcal Polysaccharide Vaccine Market Size, by Application, 2017-2032 (USD Million)
TABLE 262. Japan Group A & C Meningococcal Polysaccharide Vaccine Market Size, by Emergency Vaccination, 2017-2032 (USD Million)
TABLE 263. Australia Group A & C Meningococcal Polysaccharide Vaccine Market Size, 2017-2032 (USD Million)
TABLE 264. Australia Group A & C Meningococcal Polysaccharide Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 265. Australia Group A & C Meningococcal Polysaccharide Vaccine Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 266. Australia Group A & C Meningococcal Polysaccharide Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 267. Australia Group A & C Meningococcal Polysaccharide Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 268. Australia Group A & C Meningococcal Polysaccharide Vaccine Market Size, by Sales Type, 2017-2032 (USD Million)
TABLE 269. Australia Group A & C Meningococcal Polysaccharide Vaccine Market Size, by Application, 2017-2032 (USD Million)
TABLE 270. Australia Group A & C Meningococcal Polysaccharide Vaccine Market Size, by Emergency Vaccination, 2017-2032 (USD Million)
TABLE 271. South Korea Group A & C Meningococcal Polysaccharide Vaccine Market Size, 2017-2032 (USD Million)
TABLE 272. South Korea Group A & C Meningococcal Polysaccharide Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 273. South Korea Group A & C Meningococcal Polysaccharide Vaccine Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 274. South Korea Group A & C Meningococcal Polysaccharide Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 275. South Korea Group A & C Meningococcal Polysaccharide Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 276. South Korea Group A & C Meningococcal Polysaccharide Vaccine Market Size, by Sales Type, 2017-2032 (USD Million)
TABLE 277. South Korea Group A & C Meningococcal Polysaccharide Vaccine Market Size, by Application, 2017-2032 (USD Million)
TABLE 278. South Korea Group A & C Meningococcal Polysaccharide Vaccine Market Size, by Emergency Vaccination, 2017-2032 (USD Million)
TABLE 279. Global Group A & C Meningococcal Polysaccharide Vaccine Market Share, by Key Player, 2025
TABLE 280. Global Group A & C Meningococcal Polysaccharide Vaccine Market, Key Experts

Companies Mentioned

  • Bharat Biotech International Limited
  • Cadila Healthcare Limited
  • China National Pharmaceutical Group Co., Ltd.
  • GlaxoSmithKline plc
  • Hualan Biological Engineering Inc.
  • Panacea Biotec Limited
  • PT Bio Farma (Persero)
  • Sanofi S.A.
  • Serum Institute of India Private Limited

Related Topics

Related Reports

Prevent Meningitis Vaccine Market - Global Forecast 2026-2032 - Product Image

Prevent Meningitis Vaccine Market - Global Forecast 2026-2032

  • Report
  • 183 Pages
  • Global
From
Meningococcal Vaccines Market - Global Forecast 2026-2032 - Product Image

Meningococcal Vaccines Market - Global Forecast 2026-2032

  • Report
  • 188 Pages
  • Global
From
Meningococcal Vaccines - Global Strategic Business Report - Product Image

Meningococcal Vaccines - Global Strategic Business Report

  • Report
  • 142 Pages
  • Global
From
Meningococcal Vaccines Market Report by Vaccine Type, Composition, Vaccine Serotype, Distribution Channel, End User, and Region 2026-2034 - Product Image

Meningococcal Vaccines Market Report by Vaccine Type, Composition, Vaccine Serotype, Distribution Channel, End User, and Region 2026-2034

  • Report
  • 147 Pages
  • Global
From
Meningococcal Disease Vaccine Market Report 2026 - Product Image

Meningococcal Disease Vaccine Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.